TrialMedical science monitor basic research2013

Preclinical study and phase I clinical safety evaluation of recombinant Mycobacterium tuberculosis ESAT6 protein.

Wei-Xin Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.